Savoy Pharmaceuticals™, a privately held company, is developing innovative products with the potential to treat many types of cancer and terminal viral diseases including: liver cancer, pancreatic cancer, breast cancer, colon cancer, Hepatitis C, HIV, and Herpes. In pre-clinical trials Savoy's products have been shown to have little to no effect on normal cells. This makes it the first of its kind to treat terminal diseases while leaving normal, healthy tissue unharmed.
Savoy currently has two products under development:
ONCOPREV™ for the safe, effective treatment of Cancer
VIROPREV™ for the safe, effective treatment of terminal viral diseases
To alleviate human suffering by developing targeted, innovative products in the fields of oncology, virology, and immunology.